Resolution of hydronephrosis due to massive mesenteric fibromatosis using cyclo-oxygenase 2 inhibitors.
Urology
; 70(3): 591.e3-4, 2007 Sep.
Article
en En
| MEDLINE
| ID: mdl-17905129
Mesenteric fibromatosis is currently a diagnostic and therapeutic challenge. We report a case of mesenteric fibromatosis in a 29-year-old man with a 2-month history of periumbilical fullness who was discovered to have an abdominal mass with hydronephrosis. To the best of our knowledge, we report the first case of hydronephrosis in a mesenteric fibromatosis with Gardner's syndrome, which was successfully treated with a cyclo-oxygenase 2 inhibitor without surgical removal of the mesenteric fibromatosis. The hydronephrosis and mesenteric fibromatosis improved modestly with long-term celecoxib (200 mg twice daily). Our case also highlights the importance of performing a detailed examination in patients with hydronephrosis.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias Peritoneales
/
Pirazoles
/
Sulfonamidas
/
Inhibidores de la Ciclooxigenasa 2
/
Fibroma
/
Hidronefrosis
/
Mesenterio
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Urology
Año:
2007
Tipo del documento:
Article
País de afiliación:
Taiwán